EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Review on Psoriasis Disease

Prashant S Malpure, Gayatri R Kadam, Sakshi D Chitte, Gaurav S Kale

Asian Journal of Pharmaceutical Research and Development · 2022

DOI: 10.22270/ajprd.v10i1.1084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Journal of Pharmaceutical Research and Development, 2022. Verfasst von Prashant S Malpure und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is an autoimmune disease characterised by the proliferation of keratinocytes throughout time. On average, it affects 2-5 percent of the world's population. Psoriasis treatment remains difficult due to a variety of factors influencing treatment, including patient compliance and adherence to therapy, delicate patient profiles, psychological factors, and skin as a barrier to topical delivery. Pathophysiology, triggering factors, and clinical categorization were covered in the first section. Topical, oral, biological, parenteral therapy, phototherapy, and phytopharmaceuticals were all covered in the second section.

Zitieren

APA

Malpure, P. S., Kadam, G. R., Chitte, S. D., & Kale, G. S. (2022). Review on Psoriasis Disease. Asian Journal of Pharmaceutical Research and Development. https://doi.org/10.22270/ajprd.v10i1.1084

Vancouver

Malpure PS, Kadam GR, Chitte SD, Kale GS. Review on Psoriasis Disease. Asian Journal of Pharmaceutical Research and Development. 2022. doi:10.22270/ajprd.v10i1.1084

BibTeX
@article{Malpure2022,
  author = {Malpure, Prashant S and Kadam, Gayatri R and Chitte, Sakshi D and Kale, Gaurav S},
  title = {Review on Psoriasis Disease},
  journal = {Asian Journal of Pharmaceutical Research and Development},
  year = {2022},
  doi = {10.22270/ajprd.v10i1.1084}
}
Kostenlos starten →